Gastroenterology Nursing最新文献

Inflammatory bowel disease is a type of chronic gastrointestinal inflammatory disease. The chronic nature of the disease, the severity of its symptoms, and its unpredictability make it comparable to cancers regarding both its influence on quality of life and the direct and indirect health costs. The impact of inflammatory bowel disease on daily life is well documented; however, despite the notable increase in the incidence of inflammatory bowel disease in recent years, the international literature still does not adequately take into account the perspective of patients and how they experience the disease in their daily lives. With Cohen's phenomenology method, we investigate the lived experience of people suffering from inflammatory bowel disease. Our sample included 21 participants with an average age of 47 years. Three main themes and related subthemes emerged: A "deep life change" with the subtheme of "self-isolation," being "invisibly sick," and "receiving the diagnosis" with the subtheme of "trust in health professionals." Understanding the lived experiences of people living with inflammatory bowel disease will aid in the development of educational programs and effective interventions.

Living with celiac disease (CD), a chronic autoimmune condition, leads to a variety of challenges in daily life for the affected individual. The aim of this study was to describe perceptions of CD from the perspective of persons living with the condition. A total of 157 free text comments from a questionnaire sent to persons in a Celiac Disease Member Association was analyzed using qualitative content analysis. The findings are presented in two categories. "Personal explanations of causes" describes the respondents' thoughts about different medical aspects of the disease and thoughts about their diagnosis and the onset of the disease. "My everyday life with the condition" describes how respondents perceive how the disease affects life on many levels: emotionally, socially, and physically. Living with CD impacts lives, and early diagnosis seems to have a calming effect and improve everyday life. Follow-up reception after the diagnosis was expressed as valuable, as questions arise during the disease trajectory. Counseling by health care personnel with specific knowledge regarding CD from diagnosis onwards seems vital, as the only available treatment is a gluten-free diet.

Patients with acute pancreatitis usually recover within a few weeks. Resumption of exposure to risk factors results in the recurrence of pancreatitis and readmission. This study aimed to identify the predictors of readmission among acute pancreatitis patients. A retrospective study design was adopted where the medical records of patients admitted with acute pancreatitis between January 2019 and December 2020 were included. To determine the predictors for readmission, tools such as demographics, clinical proforma, and checklists on predictors of readmission were utilized. The data were analyzed using descriptive (frequency and percentage) and inferential statistics (logistic regression). The readmission rate among adults with acute pancreatitis was 36%. Most of the patients belonged to the age group of 36-55 years. The predominant risk factors identified causing acute pancreatitis were alcohol abuse, gallstones, and idiopathic factors. A higher rate of readmission was seen in alcoholic acute pancreatitis (60.9%) and patients with moderately severe acute pancreatitis (56.1%). At index admission, 30.9% of patients had type 2 diabetes mellitus, 38.7% were alcohol dependent, 41.3% had peripancreatic collection, 12.2% had pseudocyst, and 13% had walled-off necrosis. These factors were the predictors for readmission in patients with acute pancreatitis. A focus on the predictors of readmission with early interventions that prevent complications during the index admission may reduce the risk of readmission in acute pancreatitis.

At a gastrointestinal endoscopy unit in a large, urban hospital system, the standard preparation (prep) for colonoscopy procedures was a combination of polyethylene glycol 3350 with electrolytes (Golytely) in addition to magnesium citrate until magnesium citrate underwent a national recall in July 2022. At the time of the recall, the facility had over 800 patients scheduled who had already received the recalled medication. The methods used in this project include collaboration with the interdisciplinary team to handle all aspects of the recall with a systematic approach and utilization of this unforeseen event to initiate tracking bowel prep compliance and prep quality with varied types of bowel preps utilizing a bowel prep rating scale. Of the over 800 patients scheduled at the time of the recall, 99.6% were prevented from ingesting the recalled medication. The colonoscopy prep compliance rate was 82.3%, and bowel prep quality was considered adequate in 97.7% of completed outpatient colonoscopies. This article highlights the importance of working with an interdisciplinary team during unplanned large-scale events to provide safe and effective care to patients, as well as finding positives in a challenging situation. This project includes the following commercial content: magnesium citrate, Golytely, MoviPrep, and Boston Bowel Preparation Score.